Invesco Biotechnology & Genome ETF
PBE
#1955
ETF rank
NZ$0.77 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$179.81
Share price
-1.34%
Change (1 day)
37.77%
Change (1 year)

Invesco Biotechnology & Genome ETF - Holdings

Etf holdings as of October 29, 2026Number of holdings: 33

Full holdings list

Weight %NameTickerShares Held
6.17%
Natera IncNTRA63157
6.15%
Illumina IncILMN94523
5.39%
Biogen IncBIIB96330
5.31%
Gilead Sciences IncGILD142946
5.06%
Royalty Pharma PLCRPRX342618
4.97%
Amgen IncAMGN48086
4.68%
Regeneron Pharmaceuticals IncREGN25513
4.66%
Vertex Pharmaceuticals IncVRTX38468
3.65%
Moderna IncMRNA73039
3.12%
Halozyme Therapeutics IncHALO106110
3.08%
Veracyte IncVCYT263393
3.04%
Exelixis IncEXEL204511
3.00%
QIAGEN NVQGEN265744.3786
2.98%
United Therapeutics CorpUTHR22371
2.88%
Novavax IncNVAX1228795
2.73%
TG Therapeutics IncTGTX209306
2.72%
Legend Biotech CorpLEGN544590
2.70%
Repligen CorpRGEN63845
2.64%
Sarepta Therapeutics IncSRPT613099
2.58%
Vericel CorpVCEL268389
2.49%
Protagonist Therapeutics IncPTGX77028
2.48%
Neurocrine Biosciences IncNBIX75636
2.34%
Incyte CorpINCY89424
2.28%
PTC Therapeutics IncPTCT157887
2.27%
Collegium Pharmaceutical IncCOLL422271
2.26%
BioMarin Pharmaceutical IncBMRN175436
2.25%
BioCryst Pharmaceuticals IncBCRX1180043
2.17%
AnaptysBio IncANAB198729
2.13%
Ardelyx IncARDX3068736
1.77%
ACADIA Pharmaceuticals IncACAD379453
0.04%
Invesco Government & Agency PortfolioAGPXX163618.21
0.00%
CASH & EQUIVALENTSUSD5728
0.00%
USD Pending DividendsUSDPDV0